Three researchers share the prize for discovering channelrhodopsin, a light-sensitive protein now being tested to restore vision in retinal disease.
|Articles|February 26, 2021
- February digital edition 2021
- Volume 13
- Issue 2
Quiz: Patient experiences sudden decrease in vision
Author(s)Brooke Henson, Editor
quick quiz
Advertisement
What is the most common visual field defect seen in ischemic optic neuropathy?
A. Central scotoma
B. Altitudinal
C. Arcuate
D. Cecocentral
Articles in this issue
over 5 years ago
Soft toric lens fitting practices not meeting patient needsover 5 years ago
Review Duane’s retraction syndrome diagnosis and treatmentover 5 years ago
Point-of-care testing helps dry eye diagnosisover 5 years ago
Patient experiences sudden decrease in visionover 5 years ago
How to improve telehealthover 5 years ago
High IOP, uveitis lead to Posner-Schlossman diagnosisover 5 years ago
Differential key to diagnosing idiopathic orbital inflammationalmost 6 years ago
How to avoid patient nonadherenceAdvertisement
Related to this article
Thomas Wong, OD, FAAO, details a session he presented alongside Ronald Gentile, MD, FACS, FASRS, at AAOpt 2026.
Raman Bhakhri, OD, FAAO, alongside Xiao Yu, OD, FAAO, discussed emerging investigational therapies for the disease during their AAOpt 2026 session.
Mohammad Rafieetary, OD, FAAO, FORS, DipABO, ABCMO, details his AAOpt 2026 presentation "Photobiomodulation in Age-Related Macular Degeneration: Evidence, Mechanisms, and Clinical Integration."
Raman Bhakhri, OD, FAAO, details a session given with Denise Skiadopoulos, OD, FAAO, during the annual AAOpt meeting in Anaheim, California.
Sherrol Reynolds, OD, FAAO, details her session "GLP-1RAs and Ocular Health: AOA Guidance for Optometric Practice 2025" during AAOpt 2026.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
FDA approves phentolamine ophthalmic solution 0.75% (Ryzumvi) for presbyopia
2
FDA approves Brytly eye drops for ocular redness relief lasting up to 12 hours
3
Missed AAOpt 2026? Here are the highlights by specialty
4
FDA approves subcutaneous Enspryng for TED
5